Low-molecular-weight heparin during instability in coronary artery disease

Lancet

Volumn 347, Issue 9001, 1996, Pages 561-568

  Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TIME; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 9044243412     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91270-2     Document Type: Article

References (30)

1. Lewis DH, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396-403.
2. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicentre trial. N Engl J Med 1985; 313: 1369-75.
3. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105-11.
4. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
5. Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1981; i: 1225-28.
6. Théroux P, Waters D, Qiu S, et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993; 88: 2045-48.
7. Théroux P, Waters D, Lam J, et al. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992; 327: 141-45.
8. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Circulation 1994; 89: 81-88.
9. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68.
10. Hoffmeister HM, Jur M, Wendel HP, Heller W, Seipel L. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina. Circulation 1995; 91: 2520-27.
11. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994; 309: 299-304.
12. Green D, Hirsh J, Heit J, et al. Low molecular weight heparin: a critical analysis of clinical trials. Am Soc Pharmacol Exp Therapeutics 1994; 46: 89-109.
13. Hirsh J, Levine MN. Low molecular weight heparin. J Am Soc Hematol 1992; 79: 1-17.
14. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with "stabilized" unstable angina. Circulation 1995; 91: 2319-24.
15. Théroux P. Angiographic and clinical progression in unstable angina. Circulation 1995; 91: 2295-98.
16. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-46.
17. Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis 1994; 24: 69-80.
18. Eriksson BI, Söderberg K, Widlung L, Wandell B, Tengborn L, Risberg B. A comparative study of three low-molecular weight heparins and unfractionated heparin (UH) in healthy volunteers. Thromb Haemost 1995; 73: 398-401.
19. Samama MM, Bara L, Gerotziafas GT. Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs). Haemostasis 1994; 24: 105-17.
20. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-35.
21. Monreal M, Lafoz E, Olive A, del Riko L, Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7-11.
22. Holdright D, Patel, D, Cunningham D, et al. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994; 24: 39-45.
23. Neri Serneri GGN, Gensini GF, Poggesi L. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet 1990; 335: 615-18.
24. Neri Serneri GG, Modesti PA, Gensini GF, et al. Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Lancet 1995; 345: 1201-04.
25. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994; 128: 7-11.
26. Swahn E, von Schenck H, Wallentin L. Plasma fibrinogen in unstable coronary artery disease. Scand J Clin Lab Invest 1989; 49: 49-54.
27. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994; 89: 1545-56.
28. Serneri GG, Gensini GF, Carnovali M, Rovelli F, Pirelli S, Fortini A. Effectiveness of low-dose heparin in prevention of myocardial infarction. Lancet 1987; i: 937-42.
29. Nyman I, Wallentin L, Areskog M, Areskog N-H, Swahn E, and the RISC study group. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. Int J Cardiol 1993; 39: 131-42.
30. Nyman I, Larsson H, Areskog M, Areskog N-H, Wallentin L, and the RISC study group. The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. Am Heart J 1992; 123: 324-31.